Adela, Inc.
Biotechnology · FOSTER CITY, CA
BiotechnologySEC Form D
Adela, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 23, 2026, reporting $5,000,000 raised.
Incorporated in Delaware and based in FOSTER CITY, CA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Adela, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Lisa AldersonExecutive Officer · Director
- David BonitaDirector
- Paul BrownDirector
- Daniel Diniz De CarvalhoExecutive Officer
- Abraham KometzDirector
- Anne-Renee HartmanExecutive Officer
- Maneesh JainDirector
- David ScheerExecutive Officer · Director
- Robert WeisskoffDirector
- Alan WilliamsExecutive Officer
- Scott BratmanExecutive Officer
- Lindsay MateoExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised